Related Experiment Video
Updated: Jan 27, 2026
08:30
Microinjectrode System for Combined Drug Infusion and Electrophysiology
Published on: November 13, 2019
7.3K
Two-Drug Combinations as First-Step Antihypertensive Treatment
Giuseppe Mancia1, Federico Rea2, Giovanni Corrao2
1From the University of Milano-Bicocca, Italy (G.M.).
Circulation Research
|March 29, 2019
Summary
Achieving blood pressure control in hypertensive patients remains challenging globally. Combination drug therapy is crucial for effective hypertension management, especially as a first-line treatment, to overcome therapeutic inertia.
Area of Science:
- Cardiology
- Pharmacology
- Public Health
Background:
- Worldwide, blood pressure (BP) control in hypertensive patients is largely unsatisfactory.
- Contributing factors include inadequate healthcare policies, poor patient adherence, and physician therapeutic inertia.
- Limited use of combination drug therapy, despite its proven efficacy, hinders effective BP management.
Purpose of the Study:
- To examine the current state of BP control in hypertension.
- To review the significance of drug combination strategies in hypertension treatment.
- To emphasize combination therapy as a first-line intervention based on 2018 ESC/ESH guidelines.
Main Methods:
- Review of existing literature on BP control and hypertension management.
- Analysis of recommendations from the 2018 European Society of Cardiology/European Society of Hypertension guidelines.
- Discussion of combination drug treatment strategies versus monotherapy.
Main Results:
- Combination drug treatment offers superior BP control compared to monotherapy, particularly in difficult-to-treat hypertension.
- Combination therapy facilitates easier and quicker achievement of BP control.
- The 2018 ESC/ESH guidelines support combination therapy.
Conclusions:
- Combination drug treatment should be strongly considered as a first-step intervention for hypertension.
- Addressing barriers to initial combination therapy is essential for improving patient outcomes.
- Effective BP management requires overcoming therapeutic inertia and promoting evidence-based treatment strategies.
Related Concept Videos
01:23Antihypertensive Drugs: Vasodilators
2.1K
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
2.1K
01:16Antihypertensive Drugs: Action of Diuretics
2.4K
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
2.4K
01:15Antihypertensive Drugs: Thiazide-Class Diuretics
1.8K
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
1.8K
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
2.2K
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.2K
01:25Antihypertensive Drugs: Direct Renin Inhibitors
1.4K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.4K
01:28Antihypertensive Drugs: Types of β-Blockers
1.6K
β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and...
1.6K